INVO Bioscience, Inc. (NASDAQ:INVO) Short Interest Down 96.6% in September

INVO Bioscience, Inc. (NASDAQ:INVO) saw a large decrease in short interest in the month of September. As of September 30th, there was short interest totalling 2,000 shares, a decrease of 96.6% from the September 15th total of 58,900 shares. Based on an average daily trading volume, of 174,300 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.1% of the shares of the company are short sold.

INVO Bioscience Trading Down 6.7 %

Shares of INVO Bioscience stock traded down $0.05 during trading on Thursday, hitting $0.68. 7,876 shares of the company’s stock were exchanged, compared to its average volume of 1,326,868. INVO Bioscience has a 52-week low of $0.50 and a 52-week high of $3.50. The business has a 50-day simple moving average of $0.78 and a 200-day simple moving average of $0.87.

INVO Bioscience (NASDAQ:INVO) last released its quarterly earnings data on Wednesday, August 14th. The company reported ($0.62) earnings per share for the quarter. The business had revenue of $1.84 million during the quarter.

About INVO Bioscience

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.